{"id":"W3064741431","doi":"10.1158/1078-0432.ccr-20-0037","title":"Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; Canadian Association of Thoracic Surgeons; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; FUJIFILM Pharmaceuticals U.S.A.; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; Medicine; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Antibody; Dosimetry; Monoclonal antibody; Cancer; Toxicity; Internal medicine; Cancer research; Pathology; Oncology; Nuclear medicine; Phases of clinical research; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000886203,0.001415422,0.001530833,0.000394535,0.0004339242,0.0007902605,0.0009273995,0.001034349,0.001664606],"category_scores_gemma":[0.0003759311,0.0004814769,0.0008174715,0.0003720628,0.000765316,0.0005215207,0.0002724605,0.002370568,0.0006190738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001023625,"about_ca_system_score_gemma":0.001391553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001343358,"about_ca_topic_score_gemma":0.001485221,"domain_scores_codex":[0.9996924,0.000107155,0.00001415143,0.00006183114,0.00003879857,0.00008561191],"domain_scores_gemma":[0.9995822,0.0000623035,0.00008763156,0.0000538417,0.00004274505,0.0001713115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1577573,0.1299751,0.008715374,0.0009673134,0.001173026,0.0006495551,0.000643247,0.008402282,0.5871554,0.0006615224,0.005312183,0.09858765],"study_design_scores_gemma":[0.1055339,0.7697,0.01510172,0.00004565407,0.0004973623,0.0009330433,0.0001026446,0.005025074,0.09799542,0.0002392894,0.004785697,0.00004023003],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956033,0.0007099205,0.0010486,0.000139043,0.00005365393,0.001164038,0.0003564739,0.0001007454,0.0008241865],"genre_scores_gemma":[0.9914576,0.0008208908,0.002021537,0.0002945896,0.00007260745,0.001514178,0.001887439,0.00004684421,0.001884299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001664606,"threshold_uncertainty_score":0.007426918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.352634513895786,"score_gpt":0.6222635232220715,"score_spread":0.2696290093262854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}